Entrobar

Generic name:barium sulfate suspension
Dosage form: oral suspension
Drug class:Non-iodinated contrast media

Medically reviewed by Drugs.com. Last updated on Oct 22, 2021.

Disclaimer: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Entrobar Description

Entrobar is a raspberry flavored barium sulfate suspension. It is a contrast medium developed for use in enteroclysis and follow-through x-ray examinations of the small intestine.

The product contains 50% w/v barium sulfate USP, suspending and dispersing agents, simethicone, citric acid, potassium sorbate, flavoring, sodium citrate, saccharin sodium and water. Barium sulfate has the empirical formula of BaSO4.

Entrobar - Clinical Pharmacology

Barium sulfate is an insoluble material which, because of its density, provides a positive contrast during x-ray examination. Barium sulfate is an inert radiopaque material which is not absorbed or metabolized and is eliminated intact from the body in a manner similar to other non-absorbed inorganic materials. Excretion rate is a function of gastrointestinal transit time.

Indications and Usage for Entrobar

Entrobar is indicated for use in small bowel contrast x-ray examinations. The professional literature indicates that enteroclysis is the preferred procedure in radiographic evaluation of:

• Intermittent or partial small bowel obstruction.

• Occult gastrointestinal bleeding when gastroduodenal or colon evaluation is unrevealing.

• Crohn’s disease when surgery is contemplated or when clinical suspicion is high and the follow-through is non-diagnostic.

• Clinically diagnosed malabsorption for the demonstration of structural abnormalities.

• When contrast evaluation of the small bowel is needed in very elderly or critically ill patients.

Contraindications

Barium sulfate products are contraindicated in patients with known or suspected obstruction of the colon, known or suspected gastrointestinal tract perforation, suspected tracheoesophageal fistula, obstructing lesions of the sma